Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04402437 · ClinicalTrials.gov registry record · NA

QL vs LP Blocks for Analgesia Following THA

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
111
Enrollment target

NCT04402437: Completed NA study, sponsored by Medical University of South Carolina.

NCT04402437 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 111 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04402437, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
111 participants
Enrollment target

Study Summary

Purpose: Evaluate difference in postoperative opioid consumption when subjects receive a quadratus lumborum (QL) or lumbar plexus (LP) block preoperatively for total hip arthroplasty (THA). Hypothesis: Preoperative QL and LP blocks will result in similar postoperative opioid consumption following hip arthroplasty.

Primary Outcome

Opioid consumption including intraoperative consumption

Interventions

  • PROCEDURE LP Block
  • PROCEDURE QL Block

Trial Details

FieldValue
Enrollment Target 111 participants
Start Date 2020-07-23
Est. Completion 2021-06-04
Phase NA

What the finished NCT04402437 record still lists

NCT04402437 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which LP Block is the first listed.

NCT04402437 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04402437 about?

NCT04402437 is a clinical study titled "QL vs LP Blocks for Analgesia Following THA". Purpose: Evaluate difference in postoperative opioid consumption when subjects receive a quadratus lumborum (QL) or lumbar plexus (LP) block preoperatively for total hip arthroplasty (THA). Hypothesis: Preoperative QL and LP blocks will result in similar postoperative opioid consumption following h...

What is the current status of trial NCT04402437?

This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2020-07-23. Estimated completion is 2021-06-04.

What interventions are being tested in trial NCT04402437?

The interventions under investigation include: LP Block (PROCEDURE), QL Block (PROCEDURE).

Who is sponsoring clinical trial NCT04402437?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04402437's enrollment target sits among peer trials

111 816th of 2000 higher than 1,185 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03875716 · 111 participants · NA

    Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

  • NCT04693468 · 111 participants · Phase 1

    Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial

  • NCT05263050 · 111 participants · Phase 2

    Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

  • NCT05600842 · 111 participants

    De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04402437, the US trial registry maintained by the National Library of Medicine. NCT04402437 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.